Cargando…

Hepatitis C reinfection in former and active injecting drug users in Belgium

BACKGROUND: There is currently no systematic screening for hepatitis C (HCV) reinfection in people who inject drugs (PWID) after treatment in Belgium. However, in a recent meta-analysis, the overall HCV reinfection rate was 5.9/100 person-years (PY) among PWID. Accordingly, this study was undertaken...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busschots, Dana, Bielen, Rob, Koc, Özgür M., Heyens, Leen, Verrando, Rita, de Galocsy, Chantal, Van Steenkiste, Christophe, Nevens, Frederik, Midgard, Håvard, Dalgard, Olav, Robaeys, Geert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507240/ https://www.ncbi.nlm.nih.gov/pubmed/34641896 http://dx.doi.org/10.1186/s12954-021-00552-x

Ejemplares similares

Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis
por: Busschots, Dana, et al.
Publicado: (2022)

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017
por: Koc, Özgür, et al.
Publicado: (2019)

Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium
por: Busschots, Dana, et al.
Publicado: (2021)

On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era
por: Busschots, Dana, et al.
Publicado: (2021)

Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study
por: Bielen, Rob, et al.
Publicado: (2019)

Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
por: Koc, Özgür M., et al.
Publicado: (2020)

Eliminating viral hepatitis C in Belgium: the micro-elimination approach
por: Busschots, Dana, et al.
Publicado: (2020)

Outcome in Caucasian patients with hepatitis B e antigen negative chronic infection: A long‐term observational cohort study
por: Koc, Özgür M., et al.
Publicado: (2020)

Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening
por: Koc, Özgür M., et al.
Publicado: (2019)

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach
por: Busschots, Dana, et al.
Publicado: (2022)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

A multicentre interventional study to assess blood-borne viral infections in Belgian prisons
por: Busschots, Dana, et al.
Publicado: (2021)

Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
por: Midgard, Håvard, et al.
Publicado: (2016)

The effect of universal infant vaccination on the prevalence of hepatitis B immunity in adult solid organ transplant candidates
por: Koc, Özgür M., et al.
Publicado: (2020)

Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs
por: Midgard, Håvard, et al.
Publicado: (2022)

Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium
por: Degré, Delphine, et al.
Publicado: (2017)

Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries
por: Bielen, Rob, et al.
Publicado: (2018)

The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection
por: Koc, Özgür M., et al.
Publicado: (2018)

Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression
por: Koc, Özgür Muhammet, et al.
Publicado: (2021)

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
por: Cunningham, Evan B., et al.
Publicado: (2017)

Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022
por: Berens-Riha, Nicole, et al.
Publicado: (2022)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Implementing an electronic medication overview in Belgium
por: Storms, Hannelore, et al.
Publicado: (2014)

Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non‐responders: Double‐blinded, randomised, controlled phase 2 trial
por: Koc, Özgür M., et al.
Publicado: (2021)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
por: Bielen, Rob, et al.
Publicado: (2013)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the Netherlands
por: Deckx, Laura, et al.
Publicado: (2011)

Updating ‘Perceptions and opinions on the COVID-19 pandemic in Flanders, Belgium’ with data of two additional waves of a longitudinal study()
por: De Coninck, David, et al.
Publicado: (2022)

Hepatitis C in European prisons: a call for an evidence-informed response
por: Arain, Amber, et al.
Publicado: (2014)

COVID-19 Reinfection
por: Habadi, Mohammed I, et al.
Publicado: (2021)

Advanced recorder technique : the art of playing the recorder /
por: Heyens, Gudrun‏
Publicado: (2005)

Rods, sets and arrows: the rise and fall of modern mathematics in Belgium
por: De Bock, Dirk, et al.
Publicado: (2019)

The Effect of Transborder Mobility on COVID-19 Incidences in Belgium
por: Brackx, Febe, et al.
Publicado: (2022)

Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
por: Leroy, Roos, et al.
Publicado: (2019)

Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study
por: van Halem, Karlijn, et al.
Publicado: (2020)

Perceived vulnerability to disease and attitudes towards public health measures: COVID-19 in Flanders, Belgium
por: De Coninck, David, et al.
Publicado: (2020)

Correction to: Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a etrospective cohort study
por: van Halem, Karlijn, et al.
Publicado: (2020)

Plasmodium knowlesi Reinfection in Human
por: Lau, Yee Ling, et al.
Publicado: (2011)

A Case of Reinfection with Syphilis
por: Graham, James M.
Publicado: (1912)

Cannot write session to /tmp/vufind_sessions/sess_16m99ghadds3htb3runmoaknij